January 1, 2008

Adult and Adolescent HIV Treatment Guidelines Updated

The Department of Health and Human Services has released a new version of the “Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents.”  The update includes new information on:

  • lab tests to run for newly diagnosed patients during their initial clinic visit
  • updated recommendations on when to start treatment
  • management of treatment-experienced patients, including suggestions on prescribing the recently FDA-approved drugs, Maraviroc and Raltegravir

Changes to the guidelines are summarized at the beginning of the guidelines and are highlighted in yellow throughout the text and tables.

The updated guidelines are available on the NIH AIDS info Web site.  

Next Article >

Adult and Adolescent HIV Treatment Guidelines Updated
IDSA Publishes Updated Guidelines on Aspergillus
CDC Releases Updated Immunization Schedule
Drug Approvals, Shortages, Recalls, Adverse Events
EIN Reports Problems with Vancomycin Levels
In the IDSA Journals
Outbreaks and Bioemergencies
Developing a Research Agenda for HIV and Aging
First Annual IDSA Fellows’ In-Training Exam June 3 and 4
New Resources for State and Regional Societies
CDC Finds Low Rates of Adult Immunization
IDSA Advocacy Update
New Law Requires Free Access to NIH-funded Research
Members on the Move
Welcome, New IDSA Members!
WHO Promotes Community Health Workers for HIV/AIDS Care
Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA